FDA Chief Calls For Meeting With Barr Subsidiary, Says Age Restriction In Nonprescription Plan B Application Should Be (Medical News Today)
FDA and Barr Laboratories have agreed to meet to discuss the company's application for nonprescription sales of its emergency contraceptive Plan B, FDA announced in a statement Monday, adding that it hoped remaining concerns regarding the application "can be wrapped up in a matter of weeks," the Philadelphia Inquirer reports (McCullough, Philadelphia Inquirer, 8/1). [click link for full article]